{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:19:20Z","timestamp":1784359160886,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/23446-0"],"award-info":[{"award-number":["2019\/23446-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/14343-3"],"award-info":[{"award-number":["2021\/14343-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/21629-5"],"award-info":[{"award-number":["2017\/21629-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.663310\/2022-00"],"award-info":[{"award-number":["88887.663310\/2022-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02343-z","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T02:43:00Z","timestamp":1755830580000},"page":"4517-4532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chemerin Exacerbates Pulmonary Inflammation in Type 2 Diabetes and Mycobacterium Tuberculosis Infection Comorbidity"],"prefix":"10.1007","volume":"48","author":[{"given":"Giseli Furlan","family":"Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00fabia Sabrina","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ualter Guilherme","family":"Cipriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Fl\u00e1via","family":"Gembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Bottura","family":"Apolloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra Naira","family":"Zambelli Ramalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Fernanda","family":"de Campos Fraga-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Tostes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia Luiza Deperon","family":"Bonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.soard.2011.11.001","volume":"9","author":"V Catal\u00e1n","year":"2013","unstructured":"Catal\u00e1n, V., J. G\u00f3mez-Ambrosi, and A. Rodr\u00edguez et al. 2013. Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: Tumor necrosis factor-\u03b1 stimulates mRNA levels of chemerin in visceral adipocytes from obese patients. Surg Obes Relat Dis 9:306\u2013314. https:\/\/doi.org\/10.1016\/j.soard.2011.11.001","journal-title":"Surg Obes Relat Dis"},{"key":"2343_CR2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/en.2009-1098","volume":"151","author":"MC Ernst","year":"2010","unstructured":"Ernst, M. C., M. Issa, K. B. Goralski, and C. J. Sinal. 2010. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151:1998\u20132007. https:\/\/doi.org\/10.1210\/en.2009-1098","journal-title":"Endocrinology"},{"key":"2343_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2265.2011.04217.x","volume":"77","author":"H Shin","year":"2012","unstructured":"Shin, H., D. C. Lee, and S. H. Chu et al. 2012. Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clinical Endocrinology - Oxford 77:47\u201350. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04217.x","journal-title":"Clinical Endocrinology - Oxford"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3275\/8770","volume":"36","author":"T Sledzinski","year":"2013","unstructured":"Sledzinski, T., J. Korczynska, and A. Hallmann et al. 2013. The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects. J Endocrinol Invest 36:428\u2013434. https:\/\/doi.org\/10.3275\/8770","journal-title":"J Endocrinol Invest"},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8693516","volume":"2019","author":"P Gu","year":"2019","unstructured":"Gu, P., W. Wang, and Y. Yao et al. 2019. Increased Circulating chemerin in relation to chronic microvascular complications in patients with type 2 diabetes. Int J Endocrinol 2019:1\u201311. https:\/\/doi.org\/10.1155\/2019\/8693516","journal-title":"Int J Endocrinol"},{"key":"2343_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/4468625","volume":"2021","author":"L Wang","year":"2021","unstructured":"Wang, L., Y. Zhang, and Y. Guo et al. 2021. Chemerin\/CMKLR1 Axis promotes the progression of proliferative diabetic retinopathy. Int J Endocrinol 2021:1\u20138. https:\/\/doi.org\/10.1155\/2021\/4468625","journal-title":"Int J Endocrinol"},{"key":"2343_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/obr.12009","volume":"14","author":"JL Rourke","year":"2013","unstructured":"Rourke, J.L., H.J. Dranse, and C.J. Sinal. 2013. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews 14: 245\u2013262. https:\/\/doi.org\/10.1111\/obr.12009.","journal-title":"Obesity Reviews"},{"key":"2343_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/ijms20051128","volume":"20","author":"C Buechler","year":"2019","unstructured":"Buechler, C., S. Feder, E. Haberl, and C. Aslanidis. 2019. Chemerin isoforms and activity in obesity. International Journal of Molecular Sciences 20:1128. https:\/\/doi.org\/10.3390\/ijms20051128","journal-title":"International Journal of Molecular Sciences"},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.4049\/jimmunol.0901037","volume":"183","author":"S Luangsay","year":"2009","unstructured":"Luangsay, S., V. Wittamer, B. Bondue, et al. 2009. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. The Journal of Immunology 183: 6489\u20136499. https:\/\/doi.org\/10.4049\/jimmunol.0901037.","journal-title":"The Journal of Immunology"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2011.11.004","volume":"22","author":"B Bondue","year":"2011","unstructured":"Bondue, B., V. Wittamer, and M. Parmentier. 2011. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & Growth Factor Reviews 22:331\u2013338. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.11.004","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20030382","volume":"198","author":"V Wittamer","year":"2003","unstructured":"Wittamer, V., J.-D. Franssen, M. Vulcano, et al. 2003. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 198: 977\u2013985. https:\/\/doi.org\/10.1084\/jem.20030382.","journal-title":"Journal of Experimental Medicine"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"e58709","DOI":"10.1371\/journal.pone.0058709","volume":"8","author":"M Banas","year":"2013","unstructured":"Banas, M., K. Zabieglo, and G. Kasetty et al. 2013. Chemerin is an antimicrobial agent in human epidermis. PLoS One 8:e58709. https:\/\/doi.org\/10.1371\/journal.pone.0058709","journal-title":"PLoS One"},{"key":"2343_CR13","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4049\/jimmunol.1002352","volume":"187","author":"P Kulig","year":"2011","unstructured":"Kulig, P., T. Kantyka, and B. A. Zabel et al. 2011. Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. The Journal of Immunology 187:1403\u20131410. https:\/\/doi.org\/10.4049\/jimmunol.1002352","journal-title":"The Journal of Immunology"},{"key":"2343_CR14","doi-asserted-by":"publisher","unstructured":"Bondue, B., O. Vosters, and P. de Nadai et al. 2011. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. Plos Pathogens 7. https:\/\/doi.org\/10.1371\/journal.ppat.1002358","DOI":"10.1371\/journal.ppat.1002358"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"21514","DOI":"10.1038\/s41598-021-00928-w","volume":"11","author":"M Kukla","year":"2021","unstructured":"Kukla, M., T. Men\u017cyk, and M. Dembi\u0144ski et al. 2021. Anti-inflammatory adipokines: Chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes. Scientific Reports 11:21514. https:\/\/doi.org\/10.1038\/s41598-021-00928-w","journal-title":"Scientific Reports"},{"key":"2343_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00011-014-0792-7","volume":"64","author":"F Mariani","year":"2015","unstructured":"Mariani, F., and L. Roncucci. 2015. Chemerin\/chemR23 axis in inflammation onset and resolution. Inflammation Research 64:85\u201395. https:\/\/doi.org\/10.1007\/s00011-014-0792-7","journal-title":"Inflammation Research"},{"key":"2343_CR17","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.4049\/jimmunol.1003862","volume":"186","author":"T Demoor","year":"2011","unstructured":"Demoor, T., K.R. Bracke, L.L. Dupont, et al. 2011. The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation. The Journal of Immunology 186: 5457\u20135467. https:\/\/doi.org\/10.4049\/jimmunol.1003862.","journal-title":"The Journal of Immunology"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/all.12408","volume":"69","author":"L Zhao","year":"2014","unstructured":"Zhao, L., W. Yang, X. Yang, et al. 2014. Chemerin suppresses murine allergic asthma by inhibiting CCL2 production and subsequent airway recruitment of inflammatory dendritic cells. Allergy 69: 763\u2013774. https:\/\/doi.org\/10.1111\/all.12408.","journal-title":"Allergy"},{"key":"2343_CR19","unstructured":"World Health Organization (WHO). 2024. Global Tuberculosis Report 2024. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024. Acessed 16 Jun 2025."},{"key":"2343_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050152","volume":"5","author":"CY Jeon","year":"2008","unstructured":"Jeon, C.Y., and M.B. Murray. 2008. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Medicine 5: e152. https:\/\/doi.org\/10.1371\/journal.pmed.0050152.","journal-title":"PLoS Medicine"},{"key":"2343_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/eji.201344301","volume":"44","author":"N Martinez","year":"2014","unstructured":"Martinez, N., and H. Kornfeld. 2014. Diabetes and immunity to tuberculosis. European Journal of Immunology 44:617\u2013626. https:\/\/doi.org\/10.1002\/eji.201344301","journal-title":"European Journal of Immunology"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker, M.A., A.D. Harries, C.Y. Jeon, et al. 2011. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine 9: 81. https:\/\/doi.org\/10.1186\/1741-7015-9-81.","journal-title":"BMC Medicine"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra, P., S.J. Grigsby, and J.A. Philips. 2022. Immune evasion and provocation by Mycobacterium tuberculosis. Nature Reviews Microbiology 20: 750\u2013766. https:\/\/doi.org\/10.1038\/s41579-022-00763-4.","journal-title":"Nature Reviews Microbiology"},{"key":"2343_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1146571","author":"A Kayongo","year":"2023","unstructured":"Kayongo, A., B. Nyiro, T. Siddharthan, et al. 2023. Mechanisms of lung damage in tuberculosis: Implications for chronic obstructive pulmonary disease. Frontiers in Cellular and Infection Microbiology. https:\/\/doi.org\/10.3389\/fcimb.2023.1146571.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"2343_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01124-3","author":"DG Russell","year":"2025","unstructured":"Russell, D. G., N. V. Simwela, and J. T. Mattila et al. 2025. How macrophage heterogeneity affects tuberculosis disease and therapy. Nature Reviews Immunology. https:\/\/doi.org\/10.1038\/s41577-024-01124-3","journal-title":"Nature Reviews Immunology"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/infdis\/jit241","volume":"208","author":"NP Kumar","year":"2013","unstructured":"Kumar, N.P., R. Sridhar, V.V. Banurekha, et al. 2013. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. Journal of Infectious Diseases 208: 739\u2013748. https:\/\/doi.org\/10.1093\/infdis\/jit241.","journal-title":"Journal of Infectious Diseases"},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/eji.202249839","volume":"52","author":"S Panda","year":"2022","unstructured":"Panda, S., D. M. Seelan, and S. Faisal et al. 2022. Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis. European Journal of Immunology 52:1595\u20131609. https:\/\/doi.org\/10.1002\/eji.202249839","journal-title":"European Journal of Immunology"},{"key":"2343_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2015.12.026","volume":"79","author":"N Pavan Kumar","year":"2016","unstructured":"Pavan Kumar, N., D. Nair, and V. V. Banurekha et al. 2016. Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines. Cytokine 79:74\u201381. https:\/\/doi.org\/10.1016\/j.cyto.2015.12.026","journal-title":"Cytokine"},{"key":"2343_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2022.11.037","volume":"127","author":"D Eksombatchai","year":"2023","unstructured":"Eksombatchai, D., D. Jeong, J. Mok, et al. 2023. Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: A retrospective national cohort study. International Journal of Infectious Diseases 127: 1\u201310. https:\/\/doi.org\/10.1016\/j.ijid.2022.11.037.","journal-title":"International Journal of Infectious Diseases"},{"key":"2343_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/jbmr.3072","volume":"32","author":"ES Ramos-Junior","year":"2017","unstructured":"Ramos-Junior, E. S., G. A. Leite, and C. C. Carmo-Silva et al. 2017. Adipokine chemerin bridges metabolic dyslipidemia and alveolar bone loss in mice. Journal of Bone and Mineral Research 32:974\u2013984. https:\/\/doi.org\/10.1002\/jbmr.3072","journal-title":"Journal of Bone and Mineral Research"},{"key":"2343_CR31","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cells10071732","volume":"10","author":"SP Palma Albornoz","year":"2021","unstructured":"Palma Albornoz, S.P., T.F. Fraga-Silva, C. de Gembre, et al. 2021. Obesity-induced dysbiosis exacerbates IFN-\u03b3 production and pulmonary inflammation in the Mycobacterium tuberculosis infection. Cells 10: 1732. https:\/\/doi.org\/10.3390\/cells10071732.","journal-title":"Cells"},{"key":"2343_CR32","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1210\/en.2007-0175","volume":"148","author":"K Bozaoglu","year":"2007","unstructured":"Bozaoglu, K., K. Bolton, and J. McMillan et al. 2007. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148:4687\u20134694. https:\/\/doi.org\/10.1210\/en.2007-0175","journal-title":"Endocrinology"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/path.6041","volume":"259","author":"SP Palma Albornoz","year":"2023","unstructured":"Palma Albornoz, S. P., T. F. Fraga-Silva, and R. V. de Carvalho et al. 2023. Cell death induced by <\u2009scp\u2009>\u2009NLRP3 \u2013palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity\u2010tuberculosis comorbidity. The Journal of Pathology 259:291\u2013303. https:\/\/doi.org\/10.1002\/path.6041","journal-title":"The Journal of Pathology"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","volume":"9","author":"F Suriano","year":"2021","unstructured":"Suriano, F., S. Vieira-Silva, and G. Falony et al. 2021. Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: Two sides of the same coin. Microbiome 9:147. https:\/\/doi.org\/10.1186\/s40168-021-01097-8","journal-title":"Microbiome"},{"key":"2343_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi, A., N. Rahmadika, A.I. Tjahjadi, and R. Ruslami. 2020. Type 2 diabetes and its impact on the immune system. Current Diabetes Reviews 16: 442\u2013449. https:\/\/doi.org\/10.2174\/1573399815666191024085838.","journal-title":"Current Diabetes Reviews"},{"key":"2343_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/JLB.5VMR0118-021RR","volume":"104","author":"LM Frydrych","year":"2018","unstructured":"Frydrych, L. M., G. Bian, and D. E. O\u2019Lone et al. 2018. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. Journal of Leukocyte Biology 104:525\u2013534. https:\/\/doi.org\/10.1002\/JLB.5VMR0118-021RR","journal-title":"Journal of Leukocyte Biology"},{"key":"2343_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12762","volume":"152","author":"P Kumar Nathella","year":"2017","unstructured":"Kumar Nathella, P., and S. Babu. 2017. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology 152:13\u201324. https:\/\/doi.org\/10.1111\/imm.12762","journal-title":"Immunology"},{"key":"2343_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/imm.12496","volume":"146","author":"NP Kumar","year":"2015","unstructured":"Kumar, N. P., K. Moideen, and S. D. Dhakshinraj et al. 2015. Profiling leucocyte subsets in tuberculosis\u2013diabetes co-morbidity. Immunology 146:243\u2013250. https:\/\/doi.org\/10.1111\/imm.12496","journal-title":"Immunology"},{"key":"2343_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1054\/tuld.1998.0167","volume":"79","author":"C-H Wang","year":"1999","unstructured":"Wang, C-H., C-T. Yu, and H-C. Lin et al. 1999. Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tubercle and Lung Disease 79:235\u2013242. https:\/\/doi.org\/10.1054\/tuld.1998.0167","journal-title":"Tubercle and Lung Disease"},{"key":"2343_CR40","doi-asserted-by":"publisher","unstructured":"Lopez-Lopez, N., A. G. R. Martinez, and M. H. Garcia-Hernandez et al. 2018. Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis. Memorias Do Instituto Oswaldo Cruz 113. https:\/\/doi.org\/10.1590\/0074-02760170326","DOI":"10.1590\/0074-02760170326"},{"key":"2343_CR41","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.4049\/jimmunol.1000304","volume":"184","author":"T Vallerskog","year":"2010","unstructured":"Vallerskog, T., G.W. Martens, and H. Kornfeld. 2010. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. The Journal of Immunology 184: 6275\u20136282. https:\/\/doi.org\/10.4049\/jimmunol.1000304.","journal-title":"The Journal of Immunology"},{"key":"2343_CR42","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/infdis\/jiw436","volume":"214","author":"N Martinez","year":"2016","unstructured":"Martinez, N., N. Ketheesan, K. West, et al. 2016. Impaired recognition of Mycobacterium tuberculosis by alveolar macrophages from diabetic mice. Journal of Infectious Diseases 214: 1629\u20131637. https:\/\/doi.org\/10.1093\/infdis\/jiw436.","journal-title":"Journal of Infectious Diseases"},{"key":"2343_CR43","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.2174\/0929867325666171205162248","volume":"26","author":"MO-S Catalina","year":"2019","unstructured":"Catalina, MO-S., P. C. Redondo, and M. P. Granados et al. 2019. New insights into adipokines as potential biomarkers for Type-2 diabetes mellitus. Current Medicinal Chemistry 26:4119\u20134144. https:\/\/doi.org\/10.2174\/0929867325666171205162248","journal-title":"Current Medicinal Chemistry"},{"key":"2343_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biochi.2023.04.008","volume":"212","author":"J Pestel","year":"2023","unstructured":"Pestel, J., F. Blangero, and J. Watson et al. 2023. Adipokines in obesity and metabolic-related-diseases. Biochimie 212:48\u201359. https:\/\/doi.org\/10.1016\/j.biochi.2023.04.008","journal-title":"Biochimie"},{"key":"2343_CR45","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.4049\/jimmunol.1003226","volume":"187","author":"MP Lemos","year":"2011","unstructured":"Lemos, M. P., K. Y. Rhee, and J. D. McKinney. 2011. Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression. The Journal of Immunology 187:3776\u20133784. https:\/\/doi.org\/10.4049\/jimmunol.1003226","journal-title":"The Journal of Immunology"},{"key":"2343_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01086-22","author":"G Ter\u00e1n","year":"2022","unstructured":"Ter\u00e1n, G., H. Li, S.-B. Catrina, et al. 2022. High glucose and carbonyl stress impair HIF-1-regulated responses and the control of Mycobacterium tuberculosis in macrophages. Mbio. https:\/\/doi.org\/10.1128\/mbio.01086-22.","journal-title":"Mbio"},{"key":"2343_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41519-9","volume":"14","author":"N Martinez","year":"2023","unstructured":"Martinez, N., L.J. Smulan, M.L. Jameson, et al. 2023. Glycerol contributes to tuberculosis susceptibility in male mice with type 2 diabetes. Nature Communications 14: 5840. https:\/\/doi.org\/10.1038\/s41467-023-41519-9.","journal-title":"Nature Communications"},{"key":"2343_CR48","doi-asserted-by":"publisher","first-page":"H1851","DOI":"10.1152\/ajpheart.00285.2018","volume":"315","author":"KB Neves","year":"2018","unstructured":"Neves, K.B., A. Nguyen Dinh Cat, R. Alves-Lopes, et al. 2018. Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways. American Journal of Physiology-Heart and Circulatory Physiology 315: H1851\u2013H1860. https:\/\/doi.org\/10.1152\/ajpheart.00285.2018.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"2343_CR49","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/ijms19082454","volume":"19","author":"KB Neves","year":"2018","unstructured":"Neves, K.B., A.C. Montezano, R. Alves-Lopes, et al. 2018. Upregulation of Nrf2 and decreased redox signaling contribute to renoprotective effects of chemerin receptor blockade in diabetic mice. International Journal of Molecular Sciences 19: 2454. https:\/\/doi.org\/10.3390\/ijms19082454.","journal-title":"International Journal of Molecular Sciences"},{"key":"2343_CR50","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1038\/onc.2016.516","volume":"36","author":"Y Lin","year":"2017","unstructured":"Lin, Y., X. Yang, and W. Liu et al. 2017. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation. Oncogene 36:3599\u20133608. https:\/\/doi.org\/10.1038\/onc.2016.516","journal-title":"Oncogene"},{"key":"2343_CR51","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.4049\/jimmunol.0902154","volume":"185","author":"R Hart","year":"2010","unstructured":"Hart, R., and D. R. Greaves. 2010. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. The Journal of Immunology 185:3728\u20133739. https:\/\/doi.org\/10.4049\/jimmunol.0902154","journal-title":"The Journal of Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02343-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02343-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02343-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:23:05Z","timestamp":1766409785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02343-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02343-z","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were carried out in accordance with the Ribeirao Preto Medical School Ethic Committee in Animal Use (protocol numbers 116\/2018, 226\/2019, 8\/2019, 72\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}